PBMI Report Shows Changes in Pharmacy Benefit Design to Meet Cost Challenges
PBMI Releases 2016 Trends in Drug Benefit Design Report
Plano, TX (Marketwired – December 12, 2016) ―Although employers continue to cite managing drug cost trend as the number one goal, they are addressing this challenge head on by implementing significant changes in drug benefit design. This is just a sampling of the results from PBMI’s 2016 Trends in Drug Benefit Design Report released today. The report includes responses from 337 benefit leaders representing employers with an estimated 12.3 million covered lives.
“As drug costs continue to rise, it’s no surprise that this year’s report shows employers maintain focusing their goals in the areas of managing specialty and overall drug benefit cost trend,” says Jane Lutz, Executive Director of PBMI. “As employers look to the future, collaboration to design more effective benefit designs is critical.”
The following are a few of the key findings from this year’s report:
- Employers are changing pharmacy benefit designs to manage cost increases
- Plans with four or more tiers continue to grow – 38% have four or more tiers, compared to only 26% in 2012
- Use of pharmacy deductibles are common and growing with 38% having a pharmacy deductible, either specific to the drug benefit or combined with the medial benefit
- Employers are also increasing use of incentives to encourage healthy behaviors
- Rewarding members who participate in health risk assessments increased by 12%
- Use of incentives to motivate behavior change rose 17%
- Reducing copayments for members who participate in care management programs increased 1%
- The report also identifies several opportunities
- 64% do not use preferred or limited retail networks
- 47% do not send member communications to encourage mail order or on-site pharmacy use
- Only 62% of employers reporting they currently have a program in place despite epidemic rates of substance abuse
“We hope our research continues to drive meaningful conversations and brings together all stakeholders involved in benefit design creation,” adds Lutz.
PBMI will host a free webinar on December 15 at 1:30 pm EST to showcase the report. Register today. To download or request a printed copy of this report click here.
About PBMI
The Pharmacy Benefit Management Institute provides research and education to help healthcare and benefits professionals work with pharmacy benefit managers to design prescription drug benefit programs. Learn more at www.pbmi.com.
Recent Posts
-
NCPA Advocates for Medicare Drug Price Negotiation Program Overhaul Due to Pharmacy Cash Flow
With its initial rollout beginning in 2026, the Medicare Drug Price Negotiation Program has caused significant strain on the cash flow of independent pharmacies.
The National Community Pharmacists Association (NCPA) is sounding the alarm over the federal government’s implementation of the Medicare Drug Price Negotiation Program (MDPNP) after a recent survey of its members revealed significant financial distress, according to a news release.
-
Pharmacies To Face Low Cash Flow For MFP Drugs Until Fixes Emerge
A bill introduced last year aiming to ensure long-term care (LTC) pharmacies can continue to supply and dispense Medicare Part D drugs despite lower prices resulting from the price negotiation program will need to be tweaked to ensure the intended relief is retroactive, according to Alan Rosenbloom, executive director of the Senior Care Pharmacy Coalition (SCPC).
-
SCPC Applauds Inclusion of PBM Reform in Recent Spending Package Approved by U.S. House & Senate
The Senior Care Pharmacy Coalition (SCPC), the leading voice for the nation’s long-term care (LTC) pharmacy community, released the following statement about the passage of PBM reform: “SCPC applauds the passage of bipartisan pharmacy benefit manager (PBM) reform legislation by both the U.S. House and Senate, marking a significant step toward greater transparency, accountability, and fairness in the prescription drug marketplace. These […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.